Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-individual randomized comparison of Gadovist 1.0 versus Dotarem for pelvic MRI in spondylarthritides
2007-004222-24Phase 3Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Nov 2007
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gadobutrol in spondyloarthritis (SpA), polyarthritis and Polyarthropathy of pelvic region and thigh, sponsored by Goethe University Frankfurt. Primary endpoint: Technical quantitative assessment of contrast enhancement. Started Nov 2007; status: completed.
02
Drugs
gadobutrol
03
Conditions
spondyloarthritis (SpA)polyarthritisPolyarthropathy of pelvic region and thigh
Beyond the preview
Go deeper on 2007-004222-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004222-24.